Regencell Bioscience, Duolingo, and Wynn Resorts are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities of companies incorporated or headquartered in mainland China that trade on domestic exchanges such as the Shanghai and Shenzhen Stock Exchanges (A-shares) or on international venues like the Hong Kong Stock Exchange (H-shares) and U.S. markets via American Depositary Receipts (ADRs). These stocks give investors exposure to China’s economic growth and key industry sectors, with different share classes subject to varying regulatory regimes, currencies, and eligibility rules. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Shares of NASDAQ:RGC traded up $12.70 on Thursday, hitting $23.06. The stock had a trading volume of 14,443,259 shares, compared to its average volume of 14,022,655. Regencell Bioscience has a twelve month low of $0.08 and a twelve month high of $83.60.
Read Our Latest Research Report on RGC
Duolingo (DUOL)
Duolingo, Inc. operates as a mobile learning platform in the United States, the United Kingdom, and internationally. The company offers courses in 40 different languages, including Spanish, English, French, German, Italian, Portuguese, Japanese, and Chinese through its Duolingo app. It also provides a digital English language proficiency assessment exam.
Shares of NASDAQ DUOL traded down $3.80 during mid-day trading on Thursday, hitting $393.20. 300,201 shares of the stock were exchanged, compared to its average volume of 721,886. Duolingo has a twelve month low of $145.05 and a twelve month high of $544.93. The stock's fifty day simple moving average is $476.60 and its two-hundred day simple moving average is $385.98. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.68 and a current ratio of 2.68. The company has a market cap of $17.87 billion, a P/E ratio of 194.19, a PEG ratio of 3.09 and a beta of 0.89.
Read Our Latest Research Report on DUOL
Wynn Resorts (WYNN)
Wynn Resorts, Limited designs, develops, and operates integrated resorts. The company operates through four segments: Wynn Palace, Wynn Macau, Las Vegas Operations, and Encore Boston Harbor. The Wynn Palace segment operates private gaming salons and sky casinos; a luxury hotel tower with suites, and villas, including a health club, spa, salon, and pool; food and beverage outlets; retail space; meeting and convention space; and performance lake and floral art displays.
Shares of Wynn Resorts stock traded up $0.73 during trading on Thursday, reaching $105.41. The company's stock had a trading volume of 889,001 shares, compared to its average volume of 2,592,404. Wynn Resorts has a one year low of $65.25 and a one year high of $107.81. The stock has a 50-day moving average price of $89.08 and a two-hundred day moving average price of $85.40. The stock has a market capitalization of $11.02 billion, a P/E ratio of 29.36, a price-to-earnings-growth ratio of 2.88 and a beta of 1.37.
Read Our Latest Research Report on WYNN
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.